ENDECE will present “A small molecule therapy for MS patients appears to override inhibitors of oligodendrogenesis to induce remyelination” during Poster Session #754, Biomarkers and Drug Delivery Systems Topic I.05: Biomarker and Drug Discovery at Neuroscience 2016, the 46th Annual Meeting of the Society for Neuroscience (SFN) in San Diego, California.
WHO: Steven H. Nye, Ph.D., Vice President, Discovery, ENDECE, LLC
WHEN: Wednesday, November 16, 2016, 8am – 12pm PST
WHERE: San Diego Convention Center, Halls B-H
San Diego, CA